PMC:7461420 / 39416-39570 JSONTXT

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T214","span":{"begin":20,"end":24},"obj":"Disease"},{"id":"T215","span":{"begin":91,"end":95},"obj":"Disease"}],"attributes":[{"id":"A214","pred":"mondo_id","subj":"T214","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A215","pred":"mondo_id","subj":"T215","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"}],"text":" the development of SARS‐CoV‐1 Mpro inhibitors.\nCompound 29 was only weakly active against SARS‐CoV‐1 Mpro (IC50, 800 µM) also in cellular antiviral assay"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T464","span":{"begin":76,"end":82},"obj":"http://purl.obolibrary.org/obo/CLO_0001658"}],"text":" the development of SARS‐CoV‐1 Mpro inhibitors.\nCompound 29 was only weakly active against SARS‐CoV‐1 Mpro (IC50, 800 µM) also in cellular antiviral assay"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T382","span":{"begin":31,"end":46},"obj":"Chemical"},{"id":"T383","span":{"begin":36,"end":46},"obj":"Chemical"},{"id":"T384","span":{"begin":139,"end":148},"obj":"Chemical"}],"attributes":[{"id":"A382","pred":"chebi_id","subj":"T382","obj":"http://purl.obolibrary.org/obo/CHEBI_147285"},{"id":"A383","pred":"chebi_id","subj":"T383","obj":"http://purl.obolibrary.org/obo/CHEBI_35222"},{"id":"A384","pred":"chebi_id","subj":"T384","obj":"http://purl.obolibrary.org/obo/CHEBI_22587"}],"text":" the development of SARS‐CoV‐1 Mpro inhibitors.\nCompound 29 was only weakly active against SARS‐CoV‐1 Mpro (IC50, 800 µM) also in cellular antiviral assay"}

{"project":"LitCovid-PubTator","denotations":[{"id":"1200","span":{"begin":31,"end":35},"obj":"Gene"},{"id":"1210","span":{"begin":20,"end":28},"obj":"Species"},{"id":"1230","span":{"begin":102,"end":106},"obj":"Gene"},{"id":"1231","span":{"begin":91,"end":99},"obj":"Species"}],"attributes":[{"id":"A1200","pred":"tao:has_database_id","subj":"1200","obj":"Gene:8673700"},{"id":"A1210","pred":"tao:has_database_id","subj":"1210","obj":"Tax:694009"},{"id":"A1230","pred":"tao:has_database_id","subj":"1230","obj":"Gene:8673700"},{"id":"A1231","pred":"tao:has_database_id","subj":"1231","obj":"Tax:694009"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":" the development of SARS‐CoV‐1 Mpro inhibitors.\nCompound 29 was only weakly active against SARS‐CoV‐1 Mpro (IC50, 800 µM) also in cellular antiviral assay"}